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In Brief
Mü ller et al. use targeted glucose sensors to show that glucose-6-phosphate uptake by the endoplasmic reticulum of human astrocytes and its dephosphorylation in the ER by glucose-6-phosphatase-b deliver glucose to the ER lumen and sustain cellular glucose uptake. The ER lumen may provide an intracellular protected highway for glucose transport.
RESULTS
The ER of Human Astrocytes Sequesters Glucose by Uptake and Dephosphorylation of Gluose-6-Phosphate The contribution of G6Pase-a to glucose handling in tissues like liver that export glucose is clear ( Figure 1A ). G6Pase-b, which is more widely expressed, has a similar structure to G6Pase-a, and it is expressed in endoplasmic reticulum (ER) membranes with a luminally disposed catalytic site, but its function is unknown [3, 4] . The only brain cells reported to express G6Pase-b are rodent astrocytes [18] . We confirmed, by immunostaining of cortical slices from adult rat brain, that G6Pase-b is selectively expressed in astrocytes ( Figures 1B and 1C) . Using qPCR and/or immunoblotting, we established that a G6P transporter (G6PT, see Figure 1A ) and G6Pase-b, but not G6Pase-a, are also expressed in cultured human astrocytes ( Figures 1D and 1E) . Subsequent experiments examine the contribution of G6Pase-b to glucose homeostasis and energy metabolism in normal human astrocytes derived from the fetal cortex.
We used ER-targeted glucose sensors with high (K glucose D = 30 mM, ERglc30) or low affinity for glucose (K glucose D = 600 mM, ERglc600) [15, 16] to measure glucose concentrations within the ER of cultured human astrocytes (Figures 2A and 2B ). The sensors selectively detect glucose, but not G6P or 2-deoxyglucose [19] . Restoration of extracellular glucose (5 mM) to astrocytes incubated in glucose-free medium for 10 min caused a decrease in the fluorescence resonance energy transfer (FRET) ratio of ERglc600, consistent with a sustained increase in ER glucose concentration ( Figures 2C and 2Di ). There was, however, no change in the FRET ratio of the high-affinity glucose sensor (ERglc30) (Figure 2Div ). This suggests that ERglc30 is already saturated with glucose. Since ERglc30 and ERglc600 differ only within the glucose-binding site [15, 16] , it further demonstrates that the FRET changes recorded with ERglc600 are due to changes in glucose concentration rather than to other effects, for example, pH changes or changes in the fluorescence of endogenous metabolites.
Lentivirus-mediated delivery of appropriate short hairpin RNA (shRNA) effectively reduced expression of G6Pase-b without affecting G6PT ( Figure 2E ). Loss of G6Pase-b abolished accumulation of glucose by the ER (Figures 2Dii and 2F , see legends for statistical analyses). We used human G6Pase-a for rescue experiments since it has the same catalytic activity and ER expression as G6Pase-b, but it is normally expressed only in liver and kidney. Expression of G6Pase-a rescued ER glucose uptake in cells lacking G6Pase-b (Figures 2Diii and 2F ). Preincubation of astrocytes with 2-deoxyglucose to inhibit hexokinase (HK, see Figure 1A ) abolished accumulation of glucose by the ER ( Figures  2F and 2G) .
The results so far show that both HK and G6Pase-b are required for the ER to sequester glucose, suggesting that the ER may import G6P from the cytosol using G6PT, and then use the luminal catalytic site of G6Pase-b to dephosphorylate G6P to glucose ( Figure 1A ). We tested this directly using astrocytes in which the plasma membrane was permeabilized by digitonin. Addition of G6P, but not of glucose, to permeabilized astrocytes caused accumulation of glucose within the ER (Figures 3A and 3B) . This observation excludes the possibility that, in intact cells, cytosolic glucose reaches the ER lumen passively or through glucose transporters. These results demonstrate that G6Pase-b is required for uptake of glucose, imported as G6P, by the ER of human astrocytes ( Figure 3C ). This is consistent with an analysis of rodent astrocyte microsomes, where G6P uptake was attenuated in mice lacking G6PT, but unaffected by loss of G6Pase-a [18] .
G6Pase-b Is Required for Glucose Uptake, ATP Production, and Ca 2+ Uptake by ER Knockdown of G6Pase-b reduced glucose uptake by astrocytes and their intracellular ATP concentration, and both effects were partially rescued by expression of G6Pase-a (Figures 4A and 4B). We examined inositol 1,4,5-trisphosphate (IP 3 )-mediated Ca 2+ release from the ER to explore the functional consequence of losing G6Pase-b. Astrocytes were stimulated with TFLLR, a peptide agonist of the protease-activated receptor 1 (PAR 1), Figure 1 . G6Pase-b Is Expressed in Astrocytes from Rodents and Humans (A) Glucose transported into cells by glucose transporters (GLUT) is phosphorylated to G6P by HK. Glucose-exporting cells, like hepatocytes, use a G6P transporter (G6PT) to transport G6P into the ER, where it is dephosphorylated by G6Pase-a and then exported from the cell, possibly at ER-PM contact sites (top right). G6PT and G6Pase-a are viewed as adaptations that allow efficient glucose export. Astrocytes are proposed to provide neurons with a source of energy and neurotransmitter precursors by importing glucose at their perivascular endfeet, glycolytically metabolizing it, and then exporting neurotransmitter precursors and perhaps lactate at perisynaptic processes [17] . Although the importance of the lactate shuttle has been questioned [10] [11] [12] , it is clear that astrocytes provide metabolic support to neurons. Our results suggest that G6PT and G6Pase-b allow the ER of astrocytes to serve as an intracellular highway moving glucose from perivascular endfeet to perisynaptic processes. (B and C) Confocal z stacks of rat brain cortical slices immunostained for G6Pase-b and GFAP showing their colocalization. Arrows in the overlays indicate the lumen of blood vessels surrounded by astrocytes. The overlay in (C) is additionally stained with isolectin B4 to identify capillaries (blue). which is coupled to G q and thereby formation of IP 3 [20] . Loss of G6Pase-b reduced the amplitude of the PAR 1-evoked increase in cytosolic free Ca 2+ concentration ([Ca 2+ ] c ) ( Figures 4C and 4D ). Several steps between PAR1 and the increase in [Ca 2+ ] c require ATP, including G-protein activation, formation of IP 3 , regulation of IP 3 receptors by ATP, and the activities of plasma membrane (PMCA) and ER (SERCA) Ca 2+ -ATPases. We examined SERCA because it has been reported to rely on glycolysis-derived ATP, requiring both glucose uptake and glycogen degradation [21, 22] . Loss of G6Pase-b reduced the Ca 2+ content of the ER, assessed using ionomycin, by a similar amount ($70%, Figure 4E ) to the decrease in amplitude of the PAR1evoked Ca 2+ signals ( Figure 4D ). The effects of knocking down G6Pase-b were partially rescued by expression of G6Pase-a ( Figure 4 ). We have not examined the effects of G6Pase-b on other steps in the signaling sequence, but its effects on Ca 2+ uptake by the ER seem sufficient to account for the diminished Ca 2+ signals evoked by PAR 1.
DISCUSSION
Glucose occupies a central position in the metabolism of all eukaryotic cells because it is a major energy source and a precursor for many metabolic intermediates. The capacity of most cells to sequester glucose is constrained by the properties of their HK (HK I), which, unlike the isoform expressed in liver (HK IV) [23] , is saturated by prevailing glucose concentrations and feedback inhibited by G6P [24] . Glucose meets the metabolic needs of astrocytes, and it allows them to support neurons by providing them with intermediates for metabolism and neurotransmitter synthesis. A popular hypothesis suggests that lactate is exported from astrocytes to meet these needs [17] , but the importance of this ''lactate shuttle'' is disputed [10] [11] [12] . It is, however, clear that Current Biology 28, 1-6, November 5, 2018 3 neuronal activity stimulates glucose uptake at the perivascular endfeet of astrocytes [25] [26] [27] , where the glucose transporter (GLUT1) is enriched [13] . Effective support of neurotransmission by astrocytes therefore requires both efficient glucose uptake at the perivascular endfeet, and its transfer across considerable distances, several millimeters in human brain [14] , to perisynaptic processes.
We have shown that the ER of human astrocytes accumulates glucose by sequestering G6P. This requires G6Pase-b, and disrupting the sequence inhibits cellular glucose uptake, ATP production, and ER Ca 2+ uptake. In neutrophils and macrophages too, loss of G6Pase-b reduced glucose uptake, lactate, and ATP production and attenuated Ca 2+ signaling [28, 29] . We suggest two important roles for G6Pase-b in astrocytes. First, G6Pase-b sustains cellular glucose uptake by rapidly sequestering the cytosolic G6P that would otherwise inhibit HK and thereby reduce the gradient for glucose influx ( Figure 1A ) [30] [31] [32] . Evidence that diffusion of a fluorescent analog of 2-deoxyglucose is very restricted within perivascular endfeet [33] lends credence to our suggestion that G6P is likely to accumulate at sites of glucose uptake unless it is sequestered by the ER. The only other means of removing cytosolic G6P, namely, glycolysis, the pentose phosphate pathway, and glycogen synthesis are poorly suited to the task because their regulation is not tuned to the G6P concentration. Second, we suggest that G6Pase-b provides astrocytes with both a second reservoir of glucose (additional to their glycogen stores) [34] and a route by which glucose can pass through the cell protected from glycolytic enzymes ( Figure 4F ). The ER lumen provides a route, a ''Ca 2+ tunnel,'' for redistributing Ca 2+ within cells [35] . We propose that the ER fulfills a similar function for intracellular glucose transport, with G6PT transporting G6P into the ER lumen, where it is de-phosphorylated by G6Pase-b to generate free glucose.
Since glucose is not further metabolized within the ER, it can then diffuse unhindered through the ER lumen until it encounters a glucose transporter. In permeabilized cells, glucose does not readily enter the ER ( Figure 3A ), suggesting that such transporters may either selectively transport glucose out of the ER or their overall activity is low, consistent perhaps with them being concentrated at glucose-export sites ( Figure 1A) . After translocation back into the cytosol, glucose may be phosphorylated to G6P and then further metabolized to support the local needs of astrocytes for ATP, and to provide neurotransmitter precursors and lactate for export to neurons ( Figures 1A and 4F ) [36] . This intracellular glucose highway may function in many cells, but it is likely to be particularly important for astrocytes delivering glucose acquired at their perivascular endfeet to their perisynaptic processes that may be several millimeters away ( Figure 4F ).
We conclude that G6Pase-b, a widely expressed but hitherto enigmatic enzyme, fulfills two essential roles in astrocytes. By allowing rapid sequestration of G6P at perivascular endfeet, it allows sustained glucose uptake, and by delivering glucose to the ER lumen it provides a protected intracellular highway for effective delivery of glucose from perivascular endfeet to perisynaptic processes ( Figures 1A and 4F ). The complex architecture of astrocytes, where the major sites of glucose uptake and demand are widely separated, may exaggerate their need for G6Pase-b, but it seems likely that, in other cells too, G6Pase-b may both facilitate glucose uptake and its intracellular distribution.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (F) The ER of astrocytes provides an intracellular highway for glucose transport. Glucose from capillaries is transported into the perivascular endfeet of astrocytes by GLUT1 and then phosphorylated by HK to G6P, which is then metabolized in the cytosol or transported into the ER by the G6P transporter (G6PT). Within the ER, the luminal catalytic site of G6Pase-b dephosphorylates G6P to glucose. Hence, G6Pase-b both ensures removal of G6P from the cytosol, where its accumulation would inhibit HK and prevents further glucose uptake, and it delivers glucose to the ER lumen, where it is protected from further metabolism and free to diffuse. An ER glucose transporter can then return glucose to the cytosol, where its phosphorylation to G6P by HK allows it to enter glycolysis. This then provides ATP within the perisynaptic process and lactate and neurotransmitter precursors for export to neurons. Hence, G6Pase-b within the ER allows effective glucose uptake at perivascular endfeet and its transport through a protected ER highway to perisynaptic processes. Current Biology 28, 1-6, November 5, 2018 5
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STAR+METHODS KEY RESOURCES
Quantitect primer assay: GPBB QIAGEN Cat#Hs_PYGB_1_SG
Quantitect primer assay: GPMM QIAGEN Cat#Hs_PYGM_1_SG
Quantitect primer assay: GFAP QIAGEN Cat#Hs_GFAP_1_SG
Software and Algorithms Prism 5 GraphPad, La Jolla, USA https://www.graphpad.com/ samples independently obtained from at least 4 different cultures. Negative controls (exclusion of reverse-transcriptase in cDNA synthesis, or of primers during the qPCR run) were included in each assay. Quantitect primer assays were used for GAPDH, G6Pase-b, G6Pase-a, GPBB, GPMM and GFAP.
QUANTIFICATION AND STATISTICAL ANALYSIS
Analyses were performed without blinding or power calculations to predetermine sample sizes. Statistical comparisons used nonparametric tests: the Mann-Whitney test or, for multiple comparisons, the Kruskal-Wallis or Friedman test, each with Dunn's multiple comparisons test (GraphPad Prism 5, La Jolla, CA). Results are presented as means ± SEM of values from at least 3 independent experiments. Sample sizes (n) refer to independent experiments (see legends for details).
